💨 Abstract

Ophthalmologists in India are urging the government to include advanced treatments for diabetic retinopathy under the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (PM-JAY). Currently, these treatments, which include anti-VEGF and Ang-2 inhibitors, are not covered under the scheme, making them unaffordable for many patients.

Courtesy: theprint.in

Summarized by Einstein Beta 🤖